News
10-09-2012, 01:22 AM
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published in the Journal of the National Cancer Institute. Breast cancer is one of the most common causes of cancer deaths in the U.S. with approximately 39,520 women succumbing to the disease in 2011...
More... (http://www.medicalnewstoday.com/releases/251224.php)
More... (http://www.medicalnewstoday.com/releases/251224.php)